Poolbeg Pharma PLC (AIM:POLB) Termination of proposed combination with HOOKIPA

Termination of proposed combination with HOOKIPA Pharma Inc.

Further to the 2.4 announcement on 2 January 2025 on the potential combination of Poolbeg Pharma (“Poolbeg” or the “Company”) and HOOKIPA Pharma Inc (“HOOKIPA”), the Board of Poolbeg announces that it was informed yesterday that HOOKIPA has terminated discussions on the proposed combination of the two companies.

Cathal Friel, Executive Chairman of Poolbeg, said: “We were surprised and disappointed to hear of HOOKIPA’s decision to withdraw from the combination discussions. Throughout this process, we have seen strong interest in the potential of POLB 001 and we continue to be focused on maximising the potential of our in-house programmes and exploring new opportunities to generate value for our shareholders.

ENDS

About Poolbeg Pharma plc 

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company focussed on acquiring, developing and commercialising innovative medicines that will help improve the lives of patients with rare and orphan diseases and where there is a high unmet medical need. Poolbeg comprises a strong and growing portfolio of development assets. For more information, please go to www.poolbegpharma.com or follow us on Twitter and LinkedIn @PoolbegPharma.

If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned

---